GI
IART icon

GAMMA Investing’s Integra LifeSciences IART Stock Holding History

GAMMA Investing’s Portfolio IART Stock Details IART Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2026
Q3 		$147K Buy
9,055
+385
+4% +$6.65K 0.01% 1565
2026
Q2 		$156K Sell
8,670
-78
-0.9% -$1.09K 0.01% 1465
2026
Q1 		$82.4K Buy
8,748
+2,441
+39% +$26.8K ﹤0.01% 1816
2025
Q4 		$78.3K Buy
6,307
+3,742
+146% +$49.7K ﹤0.01% 1748
2025
Q3 		$36.8K Buy
2,565
+913
+55% +$12.5K ﹤0.01% 2186
2025
Q2 		$20.3K Buy
1,652
+590
+56% +$8.57K ﹤0.01% 2451
2025
Q1 		$23.4K Buy
1,062
+430
+68% +$10.1K ﹤0.01% 2292
2024
Q4 		$14.3K Buy
632
+469
+288% +$10.2K ﹤0.01% 2437
2024
Q3 		$2.96K Sell
163
-178
-52% -$4.13K ﹤0.01% 2934
2024
Q2 		$9.94K Buy
341
+263
+337% +$7.8K ﹤0.01% 2256
2024
Q1 		$2.77K Buy
78
+35
+81% +$1.4K ﹤0.01% 2639
2023
Q4 		$1.73K Buy
+43
New +$1.69K ﹤0.01% 2621

Other funds holding IART

FFA
Farther Finance Advisors San Francisco, California $14.2B AUM 18.33% 1-Year Est. Return
PS
Planning Strategies Lancaster, Pennsylvania $169M AUM
MPWT
MassMutual Private Wealth & Trust Windsor, Connecticut $3.79B AUM 19.33% 1-Year Est. Return
GWM
Gilpin Wealth Management Denver, Colorado $148M AUM 25.13% 1-Year Est. Return

GAMMA Investing's IART Position: Q3 2026 in Review

GAMMA Investing increased its Integra LifeSciences (IART) stake by 4.4% in Q3 2026, buying an estimated $6.65K and bringing the position to 9,055 shares worth $147K. The position accounts for 0.01% of the portfolio, ranked #1565.

GAMMA Investing first reported a position in IART in Q4 2023 and has held it in 12 quarters since. The position peaked at $156K in Q2 2026. 5 funds tracked by Wall St. Rank hold IART as of Q3 2026.

  • GAMMA Investing held 9,055 shares of Integra LifeSciences worth $147K as of Q3 2026.
  • GAMMA Investing bought 385 Integra LifeSciences shares in Q3 2026, an estimated $6.65K.
  • Integra LifeSciences made up 0.01% of GAMMA Investing's portfolio in Q3 2026, its #1565 holding.
  • GAMMA Investing first reported a position in Integra LifeSciences in Q4 2023 and has held it in 12 quarters since.
  • GAMMA Investing's Integra LifeSciences position peaked at $156K in Q2 2026.
  • 5 funds tracked by Wall St. Rank held Integra LifeSciences as of Q3 2026.

Based on GAMMA Investing's 13F filing for Q3 2026, filed 8 Oct 2026.